scholarly journals Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial

2018 ◽  
Vol 20 (12) ◽  
pp. 2885-2893 ◽  
Author(s):  
John B. Buse ◽  
Anders L. Carlson ◽  
Mitsuhisa Komatsu ◽  
Ofri Mosenzon ◽  
Ludger Rose ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Aspart ◽  
Insulin Degludec ◽  
Double Blind Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Blind Trial ◽  
Acting Insulin ◽  
Fast Acting

scholarly journals Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

The Lancet ◽  
2011 ◽  
Vol 378 (9788) ◽  
pp. 319-327 ◽  
Author(s):  
Diane K Wherrett ◽  
Brian Bundy ◽  
Dorothy J Becker ◽  
Linda A DiMeglio ◽  
Stephen E Gitelman ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glutamic Acid ◽  
Glutamic Acid Decarboxylase ◽  
Acid Decarboxylase ◽  
Double Blind Trial ◽  
Double Blind ◽  
Recent Onset ◽  
Blind Trial ◽  
Onset Type

scholarly journals Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial

2018 ◽  
Vol 19 (7) ◽  
pp. 1263-1270 ◽  
Author(s):  
Tadej Battelino ◽  
Larry C. Deeb ◽  
Magnus Ekelund ◽  
Ona Kinduryte ◽  
Georgeanna J. Klingensmith ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Randomized Trial ◽  
Children And Adolescents ◽  
Insulin Aspart ◽  
Fixed Combination ◽  
Insulin Degludec ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document